![Antitumor effect of a pyrazolone-based-complex [Cu(PMPP-SAL)(EtOH)] against murine melanoma B16 cell in vitro and in vivo Cover](https://sciendo-parsed.s3.eu-central-1.amazonaws.com/647076f671e4585e08a9dc20/cover-image.jpg)
References
- 1. C. Cerchia and A. Lavecchia, Small molecule drugs and targeted therapy for melanoma: Current strategies and future directions, Curr. Med. Chem. 24 (2017) 1–33; https://doi.org/10.2174/092986732466617041416393710.2174/092986732466617041416393728413965
- 2. T. Zhang, Y. R. Suryawanshi, H. M. Woyczesczyk and K. Essani, Targeting melanoma with cancerkilling viruses, Open. Virol. J. 11 (2017) 28–47; https://doi.org/10.2174/187435790171101002810.2174/1874357901711010028542017228567163
- 3. P. Diamantopoulos and H. Gogas, Melanoma immunotherapy dominates the field, Ann. Transl. Med.4 (2016) 269; https://doi.org/10.21037/atm.2016.06.3210.21037/atm.2016.06.32497137927563656
- 4. A. A. Tarhini and S. S. Agarwala, Cutaneous melanoma: available therapy for metastatic disease, Dermatol. Ther. 19 (2010) 19–25; https://doi.org/10.1111/j.1529-8019.2005.00052.x10.1111/j.1529-8019.2005.00052.x16405566
- 5. P. C. Bruijnincx and P. J. Sadler, New trends for metal complexes with anticancer activity, Curr. Opin. Chem. Biol.12 (2008) 197–206; https://doi.org/10.1016/j.cbpa.2007.11.01310.1016/j.cbpa.2007.11.013292302918155674
- 6. Y. Jung and S. J. Lippard, Direct cellular responses to platinum-induced DNA damage, Chem. Rev. 107 (2010) 1387–407; https://doi.org/10.1002/chin.20073127010.1002/chin.200731270
- 7. M. S. Soengas and S. W. Lowe, Apoptosis and melanoma chemoresistance, Oncogene22 (2003) 3138–3151; https://doi.org/10.1038/sj.onc.120645410.1038/sj.onc.120645412789290
- 8. I. E. León, V. Porro, S. Astrada, M. G. Egusquiza, C. I. Cabello, M. Bollati-Fogolin and S. B. Etcheverry, Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model, Chem. Biol. Interact. 222 (2014) 87–96; https://doi.org/10.1016/j.cbi.2014.10.01210.1016/j.cbi.2014.10.01225451568
- 9. J. Zhao, S. Gou and F. Liu, Potent anticancer activity and possible low toxicity of platinum(II) complexes with functionalized 1,1-cyclobutanedicarboxylate as a leaving ligand, Chemistry20 (2014) 15216–15225; https://doi.org/10.1002/chem.20140409010.1002/chem.20140409025256173
- 10. S. Iglesias, N. Alvarez, M. H. Torre, E. Kremer, J. Ellena, R. R. Ribeiro, R. P. Barroso, A. J. Costafilho, M. G. Kramer and G. Facchin, Synthesis, structural characterization and cytotoxic activity of ternary copper(II)-dipeptide-phenanthroline complexes. A step towards the development of new copper complexes for the treatment of cancer, J. Inorg. Biochem. 139 (2014) 117–123; https://doi.org/10.1016/j.jinorgbio.2014.06.00710.1016/j.jinorgbio.2014.06.00725033418
- 11. J. Lv, T. T. Liu, S. L. Cai, X. Wang, L. Liu and Y. M. Wang, Synthesis, structure and biological activity of cobalt (ii) and copper (ii) complexes of valine-derived Schiff bases, J. Inorg. Biochem.100 (2006) 1888–1896; https://doi.org/10.1016/j.jinorgbio.2006.07.01410.1016/j.jinorgbio.2006.07.01416965817
- 12. V. M. Leovac, G. A. Bogdanović, L. S. Jovanović, L. Joksović, V. Marković, M. D. Joksović, S. M. Denčić, A. Isaković, I. Marković and F. W. Heinemann, Synthesis, characterization and antitumor activity of polymeric copper(II) complexes with thiosemicarbazones of 3-methyl-5-oxo-1-phenyl--3-pyrazolin-4-carboxaldehyde and 5-oxo-3-phenyl-3-pyrazolin-4-carboxaldehyde, J. Inorg. Biochem.105 (2011) 1413–1421; https://doi.org/10.1016/j.jinorgbio.2011.07.02110.1016/j.jinorgbio.2011.07.02121955843
- 13. X. Q. Zhou, Y. Li, D. Y. Zhang, Y. Nie, Z. J. Li, W. Gu, X. Liu, J. L. Tian and S. P. Yan, Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis, Eur. J. Med. Chem. 114 (2016) 244–256; https://doi.org/10.1016/j.ejmech.2016.02.05510.1016/j.ejmech.2016.02.05526994692
- 14. X. H. Wang, D. Z. Jia, Y. J. Liang, S. L. Yan, Y. Ding, L. M. Chen, Z. Shi, M. S. Zeng, G. F. Liu and L. W. Fu, Lgf-YL-9 induces apoptosis in human epidermoid carcinoma KB cells and multidrug resistant KBv200 cells via reactive oxygen species-independent mitochondrial pathway, Cancer. Lett. 249 (2007) 256–270; https://doi.org/10.1016/j.canlet.2006.09.00810.1016/j.canlet.2006.09.00817055640
- 15. C. Kou, J. Zhao, Y. Li, G. Xu and S. Sun, Acute toxicity test of different doses of copper complex of pyrazolone derivatives in mice, Chin. Hosp. Pharm. J. 36 (2016) 821–825 (In Chinese).
- 16. G. C. Xu, L. Zhang, L. Liu, G. F. Liu and D. Z. Jia, Syntheses, characterization and crystal structures of mixed-ligand Cu(II), Ni(II) and Mn(II) complexes of (1-phenyl-3-methyl-4-propenylidene-5--pyrazolone)-salicylidene hydrazide containing ethanol or pyridine as a co-ligand, Polyhedron27 (2008) 12–24; https://doi.org/10.1016/j.poly.2007.08.04510.1016/j.poly.2007.08.045
- 17. J. Zhao, L. Zhang, J. Li, T. Wu, M. Wang, G. Xu, F. Zhang, L. Liu, J. Yang and S. Sun, A novel pyrazolone-based derivative induces apoptosis in human esophageal cells via reactive oxygen species (ROS) generation and caspase-dependent mitochondria-mediated pathway, Chem. Biol. Interact. 231 (2015) 1–9; https://doi.org/10.1016/j.cbi.2015.02.00410.1016/j.cbi.2015.02.00425684395
- 18. Q. L. Wu, X. P. Wu, Y. J. Liang, L. M. Chen, Y. Ding and L. W. Fu, P-glycoprotein is not involved in pathway of anti-Fas/Fas-induced apoptosis in KBv200 cells, World. J. Gastroenterol.11 (2005) 3544; https://doi.org/10.3748/wjg.v11.i23.354410.3748/wjg.v11.i23.3544431595715962371
- 19. C. Chang, T. Wu, M. Wang, G. Xu and S. Sun, Antitumor effect of cadmium(II) complex of pyrazolone derivatives on melanoma B16 cells in vitro and in vivo, Chin. J. Pharmacol. Toxicol. 31 (2017) 405–413 (In Chinese).
- 20. G. Resta, G. Anania, F. Messina, D. D. Tullio, G. Ferrocci, F. Zanzi, D. Pellegrini, R. Stano, G. Cavallesco, G. Azzena and S. Occhionorelli, Jejuno-jejunal invagination due to intestinal melanoma, World. J. Gastroenterol. 13 (2007) 310; https://doi.org/10.3748/wjg.v13.i2.31010.3748/wjg.v13.i2.310406596417226915
- 21. A. Dayton, K. Selvendiran, S. Meduru, M. Khan, M. L. Kuppusamy, S. Naidu, T. Ka´lai, K. Hideg and P. Kuppusamy, Amelioration of doxorubicin-induced cardiotoxicity by an anticancer-antioxidant dual-function complex, J. Pharmacol. Exp. Ther. 339 (2011) 350–357; https://doi.org/10.1124/jpet.111.18368110.1124/jpet.111.183681319999421799049
- 22. H. Yang, D. Chen, Q. C. Cui, X. Yuan and Q. P. Dou, Celastrol, a triterpene extracted from the chinese “thunder of god vine,” is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice, Cancer. Res. 66 (2006) 4758; https://doi.org/10.1158/0008-5472.can-05-452910.1158/0008-5472.CAN-05-452916651429
- 23. W. Jiang, J. Cao, B. Pan and Y. Yu, Clinical significance of serum vascular endothelial growth factor and b-fibroblast growth factor before and after chemotherapy in patients with small cell lung cancer, Chin. J. Clin. Oncol. 40 (2013) 638–642; https://doi.org/10.3969/j.issn.1000-8179.2013.11.006
- 24. S. Imura, H. Miyake, K. Izumi, S. Tashiro and H. Uehara, Correlation of vascular endothelial cell proliferation with microvessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in hepatocellular carcinoma, J. Med. Invest. 51 (2004) 202; https://doi.org/10.2152/jmi.51.20210.2152/jmi.51.20215460907
- 25. H. Yao, P. Cui, D. Xu, Y. Liu, Q. Tian and F. Zhang, A water-soluble polysaccharide from the roots of Polygala tenuifolia suppresses ovarian tumor growth and angiogenesis in vivo, Int. J. Biol. Macromol.107 (2018) 713–718; https://doi.org/10.1016/j.ijbiomac.2017.09.04310.1016/j.ijbiomac.2017.09.04328923567